To enter the CARB-X portfolio, successful applicants can expect the following:

Executing your agreement

• Negotiate final workplan and associated budget for initial stage of development
• Complete prequalification and due diligence exercises
• Review and sign a CARB-X Portfolio Company Agreement
• Demonstrate proof of cost share. Successful applicants must contribute cost share equal to a percentage of the total cost of the agreed work package. Please refer to the FAQ document for additional information regarding cost share.

Accelerating your project

• Internal CARB-X Research & Development Team partner (“Alliance Lead”)
• Company Support Team, a team of internal and external experts that monitors progress and provides scientific and programmatic advice
• Access to Clinical Advisory Board, a board that monitors and advises programs as they transition into clinical studies
• Participate in Portfolio Acceleration Tools
• Access to acceleration partners for business, scientific and regulatory support
• Access to NIAID Preclinical and Diagnostic services
• Access to US Department of Defense services
• Advance to Option stages following recommendation by milestone review board and positive decision by CARB-X Investment Committee
• Stewardship and access development support